1

2010 In

Review

2010 Annual Report

Janet P. Engle, PharmD, FAPhA Professor and Head Executive Associate Dean

2010 In

Review

2

Table of Contents

Message from the Head ...................................................................................................................................... 3

Department Mission Statement .......................................................................................................................... 5

Departmental Faculty ......................................................................................................................................... 6

Residents/Fellows ............................................................................................................................................... 8

Administrative Staff ............................................................................................................................................ 9

Department Section Updates ............................................................................................................................ 10

Department Research Funding .......................................................................................................................... 19

Publications ...................................................................................................................................................... 23

2010 In

Review

3

Message from the Head Janet P. Engle

The Department of Pharmacy Practice, one of the largest in the country, had an extremely productive year in 2010. At the end of 2010, the department embarked on an extensive strategic planning process. The process examined all aspects of the department including research, service, entrepreneurial and educational activities. Planning will continue throughout 2011 until all units within the department have completed planning exercises. Then, a clear blueprint for future directions of the department will be produced. The department developed a new mentoring program. The program, a requirement for anyone joining the department, matches new faculty members with established practitioners in their area of interest. A new faculty orientation program was developed and delivered for the first time in 2010. Six new faculty members participated in the program. The program will be offered on a regular basis to all new faculty hires in the department. In conjunction with the orientation, a faculty handbook was developed and distributed to all new faculty as well as others as requested. The handbook is also available electronically on the departmental website. The department studied its current procedures for promotion on the clinical track, forming an ad-hoc committee to study the issue. After several months of meetings, the ad-hoc committee presented their report. It was reviewed and edited by the Department Advisory Committee and the new policies became effective in November 2010. The residency and fellowship program had a very strong year. Applicant numbers and quality of candidates continue to increase. In 2010, all

available PGY1 and PGY2 specialty residency positions were filled. In addition, a third community pharmacy residency was added and filled. A leadership component to the program was added that allows residents to meet with the department head on a monthly basis to discuss various topics. Residents continue to do well, advancing to positions in academia, clinical practice and industry. Several networking events were held to foster increased interaction among faculty. These included an event held at US Cellular Field to see the Chicago White Sox play on Health Professionals Night and a Poster Networking Event where all departmental faculty displayed their scientific posters that had presented at national meetings throughout the year.

2010 In

Review

4

The strategic planning process includes assessing the physical facilities available to the department and making renovations as needed. In 2010, the entire residency suite was remodeled to include new work space for the residents; a state of the art

conference room with videoconferencing capabilities; and small private office spaces for interviews, conferences with students, and other

activities. Department space on the first floor was also remodeled to provide eight new offices for research personnel. Several faculty offices also were updated and new laboratory equipment was purchased. With our new campus in Rockford, efforts have been made to become acquainted with Rockford students. Each

semester the department head and assistant department head for education travel to Rockford to meet with the students and faculty to discuss topics of mutual interest. Faculty recruiting in Rockford has gone well with the addition of two new faculty members in 2010 to supplement the faculty clinicians who have been practicing in Rockford for several years. Efforts to market the seven ambulatory pharmacies also continued throughout 2010. The pharmacies have a presence on Facebook and Twitter, gaining many new followers. A blog covering health-related topics continues, supported by the Drug Information Group. New marketing pieces for campus buses, lightboxes, campus student centers and patient exam rooms were developed. Other targeted projects such as our flu vaccine campaign were also executed. It has been a busy and productive year for the department. These endeavors could not have been accomplished without the hard work of faculty, staff, residents and fellows. While not all accomplishments can be featured in this report, these highlights are just a few of the many contributions the department has made to the college, university and profession of pharmacy.

2010 In

Review

5

Department of Pharmacy Practice Mission Statement

The Department of Pharmacy Practice is an academic department within the University of Illinois at Chicago College of Pharmacy, Chicago and Rockford Campuses. The department is also a service unit that provides pharmacy services within the University of Illinois Medical Center and affiliated sites. Among the most comprehensive units of its type in the United States, the department is composed of faculty and staff who are teachers, scholars and/or practitioners. Members of the department continue a tradition of exemplary service through the following activities:

Educating and training Doctor of Pharmacy students, undergraduate and graduate students, post-PharmD residents and fellows, and practicing pharmacists, to become nationally and/or internationally recognized for their leadership, knowledge and competence in practice, research, and/or teaching roles.

Providing innovative pharmacy services across the continuum of care to the diverse patient

populations of the University of Illinois Medical Center and affiliated sites.

Creating through research, and disseminating in the biomedical literature, new scientific knowledge about the effective, safe, and economical.

Developing, evaluating and disseminating innovative educational methods for educating

pharmacist leaders of the future. Advocating professional roles for pharmacists on local, state, national and international levels.

Collaborating with other health science professionals in teaching, service and research activities.

Serving the public through the promotion of health and optimal use of medications.

Advancing the profession of pharmacy through activities in professional societies both in the

United States and internationally.

Sharing our expertise to facilitate advancement of global pharmacy education, practice and research through collaborative programs.

Creating entrepreneurial opportunities that advance pharmacy practice and further the

professional and financial interests of the department, medical center, college, and university.

2010 In

Review

6

Departmental Faculty – 2010

Sheila M. Allen, PharmD, BCPS – Clinical Assistant Professor Richard J. Anzalone, PharmD – Clinical Assistant Professor Melissa Badowski, Pharm D, BCPS, AAHIVE – Clinical Assistant Professor Patricia A. Balow, BSPharm – Clinical Assistant Professor David W. Bartels, PharmD, FCCP, CDE – Clinical Assistant Professor Jerry L. Bauman, PharmD, FCCP, FACC – Professor Peggy S. Bickham, PharmD – Clinical Assistant Professor Jeffrey R. Bishop, PharmD – Assistant Professor Leslie A. Briars, PharmD – Clinical Assistant Professor Rodrigo M. Burgos, PharmD, AAHIVE – Clinical Assistant Professor Adam Bursua, PharmD – Clinical Assistant Professor Margaret H. Young Byun, PharmD – Clinical Assistant Professor Maya Campara, PharmD, BCPS – Clinical Assistant Professor Bradley C. Cannon, PharmD – Clinical Assistant Professor Larisa H. Cavallari, PharmD – Associate Professor Isaac H. Cha, PharmD, BCPS – Clinical Assistant Professor Juliana Chan, PharmD – Clinical Assistant Professor Linda F. Chang, PharmD, MPH, BCPS – Clinical Assistant Professor Aimee B. Chevalier, PharmD – Clinical Assistant Professor John A. Crawford, BSPharm –Clinical Assistant Professor Larry H. Danziger, PharmD – Professor Robert J. DiDomenico, PharmD – Clinical Associate Professor Andrew J. Donnelly, PharmD, MBA, FASHP – Clinical Professor Beatrice Drambarean, PharmD, BCPS – Clinical Assistant Professor Sandra F. Durley, PharmD – Clinical Assistant Professor Janet P. Engle, PharmD, FAPhA – Professor James F. Fahey, PharmD – Clinical Assistant Professor Richard G. Fiscella, MPH, PharmD – Clinical Professor

James H. Fischer, PharmD, FCCP – Professor Michael P. Gabay, PharmD, JD, BCPS – Clinical Associate Professor William L. Galanter, MD, PhD – Clinical Assistant Professor John Garofalo, PharmD – Clinical Assistant Professor Jennifer M. George, PharmD – Clinical Assistant Professor Cheryl L. Gilmartin, PharmD – Clinical Assistant Professor Donna M. Givone, PharmD, BCPP – Clinical Assistant Professor Robert C. Glowacki, PharmD – Clinical Assistant Professor Christina M. Godwin, PharmD – Clinical Assistant Professor Julie Golembiewski, PharmD – Clinical Associate Professor Kristen L. Goliak, PharmD – Clinical Assistant Professor Linda M. Grider, BSPharm, MBA – Clinical Assistant Professor Shellee A. Grim, PharmD, BCPS – Clinical Associate Professor Vicki L. Groo, PharmD – Clinical Assistant Professor Christina Mactal Haaf, PharmD, BCPS – Clinical Assistant Professor Mitra Habibi, PharmD – Clinical Assistant Professor Erika L. Hellenbart, PharmD – Clinical Assistant Professor Heather J. Ipema, PharmD – Clinical Assistant Professor Gail S. Itokazu, PharmD – Clinical Associate Professor Hyun-Young Jeong, PharmD, PhD – Assistant Professor Tania G. John, PharmD – Clinical Assistant Professor Jeremy J. Johnson, PharmD, PhD – Assistant Professor Michael T. Johnson, PharmD – Clinical Assistant Professor Jamie Joseph, PharmD – Visiting Clinical Assistant Professor Marlowe D. Kachlic, PharmD – Clinical Assistant Professor Keri S. Kim, PharmD, MS, CTA, BCPS – Clinical Assistant Professor Shiyun Kim, PharmD – Clinical Assistant Professor Kelly Kopec, PharmD – Clinical Assistant Professor Michael J. Koronkowski, PharmD – Clinical Assistant Professor

7

2010 In

Review

Departmental Faculty – 2010 (continued)

James J. Kotek, PharmD – Clinical Assistant Professor Donna M. Kraus, PharmD – Associate Professor Courtney D. Krueger, PharmD, BCPS – Clinical Assistant Professor Ann M. Kuchta, PharmD – Clinical Assistant Professor Molly P. Kurpius, PharmD – Clinical Assistant Professor Sami Labib, BSPharm – Clinical Assistant Professor Alan H. Lau, PharmD, FCCP – Professor Todd A. Lee, PharmD, PhD – Associate Professor Melissa T. Leedock, PharmD – Clinical Assistant Professor Amy E. Lodolce, PharmD, BCPS – Clinical Assistant Professor Gail B. Mahady, PhD – Associate Professor Carissa E. Mancuso, PharmD – Clinical Assistant Professor Michelle Martin, PharmD – Clinical Assistant Professor Blake E. Max, PharmD – Clinical Assistant Professor John M. McBride, BSPharm – Clinical Assistant Professor Charles E. McPherson, III, PharmD – Clinical Assistant Professor Jessica B. Michaud, PharmD, BCPS – Clinical Assistant Professor Mary L. Moody, BSPharm – Clinical Assistant Professor Katherine S. Mosio, PharmD – Clinical Assistant Professor Kit Y. Moy, BSPharm – Clinical Assistant Professor Jeffrey J. Mucksavage, PharmD – Clinical Assistant Professor Jaclyn C. Y. Ng, PharmD – Clinical Assistant Professor Edith Nutescu, PharmD, FCCP – Clinical Professor Chessa R. Nyberg, PharmD –Clinical Assistant Professor Kirsten H. Ohler, PharmD, BCPS – Clinical Assistant Professor Michael J. Pacini, PharmD, BCOP – Clinical Assistant Professor Jamie L. Paek, PharmD – Clinical Assistant Professor Frank P. Paloucek, PharmD, DABAT, FASHP – Clinical Associate Professor Louise Parent-Stevens, PharmD, BCPS – Clinical Assistant Professor Jennifer H. Tran Pham, PharmD, BCPS – Clinical Assistant Professor Thuy Pham, PharmD – Clinical Assistant Professor A. Simon Pickard, PhD – Associate Professor Isabel Porto, PharmD – Clinical Assistant Professor

Sandra Cuellar Puri, PharmD, BCOP – Clinical Assistant Professor Suzanne M. Rabi, PharmD – Clinical Assistant Professor Latha Radhakrishnan, PharmD, BCPS – Clinical Assistant Professor Keith A. Rodvold, PharmD, FCCP, FIDSA – Professor Mia R. Schmiedeskamp, PharmD, PhD, BCPS – Clinical Assistant Professor Allison E. Schriever, PharmD – Clinical Assistant Professor Christopher A. Schriever, MS, PharmD, AAHIVE – Clinical Assistant Professor Heather Schumann, PharmD – Clinical Assistant Professor Glen T. Schumock, PharmD, MBA, FCCP – Professor Nancy L. Shapiro, PharmD, BCPS, FCCP – Clinical Associate Professor Daphne E. Smith-Marsh, PharmD, CDE – Clinical Assistant Professor Renata O. Smith, PharmD – Clinical Assistant Professor Rita Soni, PharmD, BCPS – Clinical Assistant Professor Joan M. Stachnik, PharmD, BCPS – Clinical Assistant Professor Joann Stubbings, MHCA – Clinical Associate Professor Sandra Kim Sung, PharmD – Clinical Assistant Professor Karen I. Sweiss, PharmD, BCOP – Clinical Assistant Professor Maria G. Tanzi-Samaan, PharmD – Clinical Assistant Professor Eljim P. Tesoro, PharmD – Clinical Assistant Professor Mathew Thambi, PharmD, MPH, BCPS – Clinical Assistant Professor James J. Thielke, PharmD – Clinical Assistant Professor Jessica J. Tilton, PharmD – Clinical Assistant Professor Daniel Touchette, PharmD, MA – Assistant Professor Raymond S. Traficante, BSPharm – Clinical Assistant Professor Anna Markel Vaysman, PharmD, BCPS – Clinical Assistant Professor Mitzi Wasik, PharmD, BCPS – Clinicat Assistant Professor Patricia M. West-Thielke, PharmD – Clinical Assistant Professor Lori A. Wilken, PharmD – Clinical Assistant Professor

8

2010 In

Review

RESIDENTS/FELLOWS

January 1, 2010 – June 30, 2010 PGY1 – Pharmacy Practice Residents Lauren Dandeles, PharmD Colleen Drasga, PharmD Ashley Hall, PharmD Julie Justo, PharmD Angela Michael, PharmD Megan Musselman, PharmD Megan Prasse, PharmD Amanda Ries, PharmD Leah Steinke, PharmD Kelly Valla, PharmD Sherilyn Van Osdol, PharmD

PGY1 – Community Pharmacy Residents Jennifer Chan, PharmD – Dominicks Emily Nufer, PharmD – SuperValu PGY2 – Specialty Residents Scott Benken, PharmD – Critical Care Kelly Cochran, PharmD – Ambulatory Care Irene Hong, PharmD – Drug Information Heather Ipema, PharmD – Drug Information Jamie Joseph, PharmD – Organ Transplantation Susan Woelich, PharmD – Oncology Diana Yu, PharmD – Infectious Diseases Research Residents/Fellows Benjamin Colton, PharmD – Infectious Diseases Tonya Crawford, PharmD – Infectious Diseases Firas Dabbous, MS – CPR, Takeda Jacqueline Jourjy, PharmD – Infectious Diseases Funda Tiryaki, PharmD, MS – CPR Fellow Caitlyn Wilke, PhD – CPR Fellow Yoojung Yang, PharmD, MS – CPR, Takeda

July 1, 2010 – December 31, 2010 PGY1 – Pharmacy Practice Residents Leena Amine, PharmD Elisabeth Donahey, PharmD Megan Hayes, PharmD Jessica Jacobson, PharmD Sean Kane, PharmD Tatyana Lawrecki, PharmD Kevin McConeghy, PharmD Mark Pangrazzi, PharmD Mabel Rodriguez, PharmD Melinda Soriano, PharmD Usasiri Srisakul, PharmD Krista Williams, PharmD PGY1 – Specialty Resident Emily Huesgen, PharmD – HIV PGY1 – Community Pharmacy Residents Caitlyn Kaminski, PharmD - SuperValu Brittany Mills, PharmD – Walgreens Quynh Nguyen, PharmD - Dominicks PGY2 – Specialty Residents Karen Berger, PharmD – Critical Care Adam Bress, PharmD – Cardiology Laura Celmins, PharmD – Emergency Medicine Lauren Dandeles, PharmD – Pediatrics Tara Gleason, PharmD – Ambulatory Care Lynley Heinrich, PharmD – Organ Transplantation Kelly Valla, PharmD – Oncology Sherilyn Van Osdol, PharmD – Drug Information Research Residents/Fellows Tonya Crawford, PharmD – Infectious Diseases Julie Justo, PharmD – Infectious Diseases Zahra Kassamali, PharmD – Infectious Diseases Rima Tawk, PhD – CPR Fellow, Takeda Funda Tiryaki, PharmD, MS – CPR Fellow Yoojung Yang, PharmD, MS – CPR Fellow

2010 In

Review

9

Pharmacy Practice Administrative Staff

Craig Conrad, BS – Assistant to the Head, Finance Arnold S. Diaz, MEd – Assistant to the Head, Human Resources Jennifer Dietrich, MBA – Senior Program Coordinator, Experiential Education Andrew J. Donnelly, PharmD, MBA, FASHP – Clinical Professor, Director of Pharmacy Janet P. Engle, PharmD, FAPhA – Professor and Head James H. Fischer, PharmD, FCCP – Professor, Assistant Head for Research Natalia Glubisz, BA – Coordinator of Grants and Contracts Kristen L. Goliak, PharmD – Clinical Assistant Professor, Assistant Head for Education Madie Nixon –Program Coordinator

2010 In

Review

10

Department Section Updates

Center for Pharmacoeconomic Research Glen Schumock, Director

In 2010, the Center for Pharmacoeconomic Research added a new faculty member, Denys Lau, PhD. Dr. Lau came from Northwestern University, with his primary faculty appointment in the Department of Pharmacy Administration. Dr. Lau is an expert in quantitative and qualitative research methodologies used to study the safety of pharmaceuticals and health services in vulnerable older adult populations. Dr. Lau’s research contributes to the impressive listing of new grants and contracts received in 2010 by the center. In total, the funding attributed to CPR faculty in 2010 was $1.5 million. There is heightened national interest in comparative effectiveness research. CPR faculty and students have been at the forefront of this movement. Efforts in this area stem from the CPR serving as the coordinating site for the Agency for Healthcare Research and Quality funded Chicago-Area DEcIDE Center. DEcIDE stands for Developing Evidence to Inform Decisions about Effectiveness. In the fall of 2010 that contract was re-competed, and CPR was one of only eight of the original DEcIDE centers to be renewed. There are now a total of 11 DEcIDE centers.

The faculty and students of the CPR continue to be actively involved in disseminating the findings of research via presentations and publications. In 2010 faculty members had a total of 39 publications in professional journals, made 56 presentations of papers/research at conferences, and were invited to deliver 29 seminar presentations at national and international meetings. Drug Information Group Mike Gabay, Director In 2010, the Drug Information Group had its most financially successful year to date. During the past year, DIG entered into new relationships with Amgen, Walgreens, Scripps Health, and Takeda Pharmaceuticals. The drug information services provided by DIG faculty continue to grow in scope as clients present unique needs. In addition, the DIG faculty completed their second year of teaching literature evaluation at Chicago State University College of Pharmacy, expanding the educational reach of UIC College of Pharmacy beyond the school itself. The DIG expanded in 2010 by hiring a new faculty member, Heather Ipema, PharmD, who completed both a PGY1 general residency and PGY2 specialty residency in drug information at UIC. Sherilyn Van Osdol, PharmD, was brought on as a new PGY2 specialty resident for the year. The Prior Authorization Group is currently in the fifth year of its contract with the Illinois Department of Healthcare and Family Services. By providing timely, clinically appropriate drug prior authorization

2010 In

Review

11

determinations for the state's Medicaid recipients, the Prior Authorization Group has helped the State of Illinois achieve tens of millions of dollars in savings in the last year alone. Some of the programs recently initiated to ensure appropriate drug utilization include psychotropic medications for young children, antipsychotic medication use in long-term care recipients, and stimulant medications for adult patients. Experiential Education Kristen Goliak, Assistant Head and Director, APPE Twenty-ten was a very successful year for the experiential education group. Negotiations began with Rush University Medical Center for their Department of Pharmacy to accept UIC College of Pharmacy students on both IPPE and APPE rotations. This exciting new partnership was successfully finalized in early 2011. Allison Schriever, PharmD, was welcomed as the director of experiential education for the Rockford campus. Dr. Schriever will work closely with the experiential team in Chicago and will be responsible for acquiring sites in and around the Rockford area. Dr. Schriever also coordinates the rural pharmacy program, RPHARM. The first UIC Walgreens PGY1 resident was accepted in 2010. Sheila Allen, PharmD, accepted the opportunity to be the faculty liaison to the program. In the fall of 2010, the IPPE program expanded to Rockford with the P1 Shadow Week. Thirty nine Rockford P1 students and 156 Chicago P1 students were placed with pharmacists, pharmacy residents and P4 students throughout the State of Illinois.

In November 2010, a preceptor conference was held. The conference was well attended by more than 100 external and internal faculty preceptors. There were also approximately 20 preceptors from Rockford who attended via ITV. This was the first interactive conference with Rockford and it went well. After the plenary sessions, each campus broke into small groups at their own site to address issues pertinent to their students and residents. Small break out group sessions in Chicago were held related to precepting residents that met ASHP requirements for CE for preceptors. It was a good opportunity for preceptors to experience the college’s new distance education modality.

In November Dr. Allen was appointed director of IPPE, working closely with Dr. Schriever in her roll with Rockford experiential program. Under the direction and guidance of Dr. Allen, several faculty, staff, residents and numerous P4 students administered 1,900 flu shots at the annual State of Illinois flu shot clinics and assisted with the administration of nearly 2,800 doses at University of Illinois Medical Center events.

2010 In

Review

12

Hospital Pharmacy Services Andy Donnelly, Director

The Departments of Hospital Pharmacy and Ambulatory Care Pharmacy play an important role in all aspects of the medication system related to the ordering, dispensing, administration and monitoring of medications at the University of Illinois Medical Center. In the past year, the department enhanced processes related to UIMC’s goals to improve patient satisfaction, patient access, and performance related to national quality measures. This was done by expanding the discharge prescription service and

decreasing length of wait times for prescriptions as well as expanding programs for patients with heart failure through hospital discharge medication instruction, adding inpatient vaccination screening program and outpatient vaccination programs for pneumonia, and addressing the need for anticoagulation by creating an inpatient oversight program and an outpatient pharmacy-run anticoagulation service. New hospital initiatives taken on include pharmacist real-time verification of all emergency department medication orders; development of processes related to ordering, verifying, dispensing and administering hazardous medications; and conversion of medication orderables to support true e-prescribing and improve accuracy of home medication lists. The ambulatory care pharmacy continued initiatives to maintain overall patient satisfaction at or above 98 percent, grow the specialty pharmacy business by 10 percent and expand the number of patients helped through the medication assistance program. Ambulatory Medicine Team Michelle Martin, Team Leader

The Ambulatory Medicine Team collaborates to host the Advanced Ambulatory Care Advanced Pharmacy Practice Experience Immunization Clerkship for fourth year students. During this rotation, students screen patients for immunizations, administer immunizations, and update patients’ medical records to reflect their current immunization status. They also maintain a database to record these interventions and work on other projects. In 2010, data that had been previously collected was analyzed and used to create four posters to showcase research. One poster was presented at American College of Clinical Pharmacy Annual Meeting in Austin, Texas in October. Three posters were presented at the

American Society of Health-System Pharmacists Midyear Clinical Meeting in Anaheim, California in December. The team plans to continue to offer this rotation to P4 students and pursue publication upon completion of a manuscript. Individual team members have been involved in multiple other publications and grant projects in 2010.

2010 In

Review

13

Antithrombosis Clinic Edith Nutescu, Clinical Manager Nancy Shapiro, Operations Manager The pharmacist-managed Antithrombosis Clinic is a clinical care unit part of the University of Illinois Medical Center and Heart Center. Currently, the clinic provides care to approximately 450 active patients and averages 8,000 patient visits a year. Since its inception, the clinic has received regional and national recognition by being selected as a Joint Commission Model Site for Disease Management and it its selection as a national training site for the American Society of Health Systems Pharmacists Research and Education Foundation Antithrombotic Traineeship. At the present time, eight clinical pharmacist faculty provide direct patient care and clinical services in the clinic. In addition to provision of direct patient care in the ATC, faculty is extensively involved in research, scholarship, teaching, and professional service activities. Critical Care Jeff Mucksavage, Team Leader The section of critical care clinical pharmacy uses the critical care environment to meet the mission goals of service, teaching, and scholarly activity. The group is comprised of eight members whose practice areas include medical surgical intensive care, cardiac intensive care, neuroscience intensive care, emergency medicine, toxicology, and anesthesia services. Members are at the forefront of clinical pharmacy practice in their respective areas and are integral members of the multidisciplinary critical care teams. Recently, there have been new additions to the team. In August 2010, Michael Johnson, PharmD, joined the group covering the medical surgical intensive care unit. The group continues to be deeply committed to the education of pharmacy students, pharmacy residents and other practitioners. Postgraduate pharmacy residency training is a notable strength of the group. In June 2010, the group graduated an American Society of Health-System Pharmacists accredited post-graduate year-2 resident in the areas of critical care. Scholarly activity is another key component to the critical care clinical pharmacy team. Critical care pharmacists are involved in investigator initiated trials as well as co-investigators on numerous multidisciplinary trials. Most notably, Keri Kim, PharmD, completed her master’s degree in clinical and translational science in May of 2010. Her additional skill set provides a welcomed resource for the group to assist in research design and implementation.

2010 In

Review

14

Family Medicine & Women’s Health Clinical Pharmacist Team Louise Parent Stevens, Team Leader The Family Medicine and Women’s Health Team provides clinical services to the Family Medicine Centers at University Village and Outpatient Care Center as well as the Women’s Health Clinic at OCC, including practitioner consults and direct patient care addressing disease state, medication management and patient education. In 2010, the team completed a project on the impact of clinical pharmacy services on the management of asthma. The team continues to participate in quality improvement projects related to patient care. With the team leader for the outpatient medicine group, the Family Medicine and Women’s Health team leader is involved in a project to evaluate the impact of the morning conference portion of the ambulatory care clerkship.

Medication Therapy Management Clinic Jessica Tilton, Manager

Medication Therapy Management Clinic is a pharmacist run clinic whose vision is to lead in medication therapy management through innovation, education and research to decrease hospitalizations, improve healthcare utilization, reduce costs and improve patients' quality of life. MTMC assists with the difficulties of accessing medications, along with simplifying the refill process to one time a month. The clinic strives to improve and sustain an acceptable medication adherence rate and prevent time lapses between refills. It ensures continuity of care with providers to improve healthcare utilization and minimize healthcare cost. MTMC sets out to prevent duplication of therapy and avoid drug interactions. It evaluates therapy to avert or minimize adverse drug events, along with assist providers in monitoring a patient’s response to therapy. Preventative measures such as immunizations and routine labs are implemented. The aim is to incorporate patient participation in self-management of medications through education. Ultimately, the clinic aspires to improve patient satisfaction with their healthcare as it relates to their drug therapy. Today MTMC is housed in the Outpatient Care Center Pharmacy where there are two private patient rooms and an additional prep area for writing notes and phone follow-up with physicians and patients. The clinic is located across

the hall from Heart Center, GI Clinic and general medicine, allowing for easy access to the patients’ physicians and nurses. There are 2.5 FTEs which includes five full-time clinical pharmacists and one manager. All pharmacists service at least one additional clinic. Patients are identified by referral from any medical center staff member. Patients are seen during half-hour face to face appointments that are scheduled using UIMCC’s scheduling system, Pathways Healthcare System. Each month the clinic averages approximately 250 patient visits, or 11.27 patient visits per day. This number continues to grow. More than 155 patients, ranging from 11 to 92 years of age, have their medications filled by the OCC pharmacy. This helps ensure the patient

receives the therapeutic regimen intended by their physicians along with providing a way to assess adherence.

2010 In

Review

15

Patients take anywhere from one to 41 medications and roughly 90 percent of patients are dual-eligible. After each patient visit, a note is placed in their electronic medical record for viewing by all their healthcare providers. In 2010, MTMC patients’ average monthly medication adherence was 95 percent. Overall, patients were above the 80 percent adherence benchmark set by multiple outcome studies. Additionally, MTMC patients blood pressure control is at 63 percent—above the national average of 34 percent stated by the seventh report of the Joint National Committee on High Blood Pressure and the 40.9 percent announced by the Agency for Healthcare Research and Quality. MTMC’s medication reconciliation rate is up to four times that of medical center physicians. Additionally, in 2010 the MTMC pharmacist team created and implemented a state wide training program called The IL Project in collaboration with Medco and the State of Illinois. The project’s goal is improve patient adherence and address omissions in drug therapy. The program has received such positive outcomes that it has been adopted in additional states. Inpatient Medicine Adam Bursua, Team Leader In addition to several awards received and publications authored by members of our inpatient medicine team, inpatient medicine faculty accomplished a great deal in 2010 to expand the influence and impact of the college. Internationally, Charles McPherson, PharmD, and Adam Bursua, PharmD, delivered educational workshops in Taiwan and Hong Kong. All faculty have enriched international relationships in the past year by mentoring trainees from overseas as arranged by the department and Alan Lau, PharmD. The college’s influence at the national level expanded as well, as Mat Thambi, PharmD, was asked to serve on an influential FDA advisory committee. Locally, outreach to the region’s seniors has continued to flourish under the leadership of Mike Koronkowski, PharmD. Demand for pharmacy faculty-led seminars has led to the addition of several senior center sites. Medicine team members also continue to serve important roles on hospital, department, college and university committees. Over the past year, members of the inpatient medicine team have lectured and provided various forms of interdisciplinary education with the Colleges of Medicine, Dentistry and Nursing. Through all of these activities, faculty remained focused on their most important roles—educating pharmacy students and improving the care of hospitalized patients. Oncology Sandra Cuellar Puri, Team Leader

The oncology pharmacy team consists of two ambulatory clinicians and two inpatient clinicians. The team collaborates on the delivery of patient care as well as academic endeavors. The academic achievements of the oncology pharmacy team vary broadly. This year, two faculty members were invited to give hematology/oncology lectures internationally. Karen Sweiss, PharmD, traveled to Japan to give lectures to Meiji University pharmacy students. Latha Radhakrishnan, PharmD, conducted an oncology workshop and presented a plenary session, titled Integrating Oncology Pharmacy Services

2010 In

Review

16

Into Comprehensive Healthcare, at the 2010 Pharmacy Practice Scientific Conference in Kuala Lumpur, Malaysia. Sandra Cuellar Puri, PharmD, was appointed as Secretary of American College of Clinical Pharmacy hematology/oncology PRN and appointed as editor-at-large for a new peer reviewed journal, Journal of Hematology Oncology Pharmacy. Christina Haaf, PharmD, presented an abstract poster at the 2011 Hematology/Oncology Pharmacy Association meeting. Dr. Haaf also serves on numerous committees within the College of Pharmacy and medical center. Recently, Dr. Radhakrishnan was elected as a member of the college’s admissions committee. The oncology pharmacy team teaches and precepts pharmacy students, PGY-1 residents, PGY-2 oncology residents, hematology/oncology medical fellows and international pharmacists throughout the academic year. Drs. Sweiss and Radhakrishnan were both nominated for the Preceptor of the Year award by the college’s Class of 2011.

Pediatric Team Update Leslie Briars, Team Leader

The pediatric team consists of six clinical pharmacists covering both inpatient and outpatient services. In the past few years, the team has collaborated on a variety of projects including an evaluation of high cost drugs like albumin and cost-savings endeavors such as providing vaccinations in the hospital through the Vaccines for Children’s Program. In the fall of 2010, three of the pediatric clinicians travelled to Hong Kong and provided a comprehensive pediatric therapeutics course to approximately 20 pharmacists. Two of the Hong Kong pharmacists then traveled to UIC in the spring of 2011 to rotate through the various clinical sites for three months of onsite training.

Solid Organ Transplant Team Jim Thielke, Team Leader

The transplant team is a newly formed team. Previously, its members were part of both ambulatory care and critical care. The expansion of the team has allowed increased coverage of all aspects for the transplant program, especially on the outpatient side. Clinicians now see transplant patients in the pre-transplant clinic, helping clear them for transplant from a medication standpoint. In addition, team members attend the pre-transplant listing meeting and evaluate all donors and recipients prior to listing for transplant. The group has already begun collaborating with multiple teams and groups from within the college. In addition, the team is working with the inpatient medicine team to pilot a new student evaluation form for clerkship rotations. Faculty hope to use this new tool in the upcoming year. Plans for the next year also include evaluation of resources to allow for the expansion of

the post-graduate transplant training program. We would like to be able to expand from our one PGY2 resident to also include a transplant fellowship/second year clinical residency program in solid organ transplant. The second year of the program would allow the trainee to focus on transplant research under the direction of Patricia West-Thielke, PharmD.

2010 In

Review

17

Rockford Pharmacy Practice David Bartels, Vice Dean

At the beginning of 2010, the Department of Pharmacy Practice had four long-standing faculty members based in Rockford. David Bartels, PharmD, vice dean and clinical professor, Rockford campus, provided administrative support for the developing Rockford campus. Dr. Bartels continued to see patients at the University Primary Care Clinic in Belvidere one day per week while lecturing and conducting workshops on a variety of topics for College of Medicine at Rockford second year pharmacology course. He continues in these capacities beyond the enrollment of the inaugural pharmacy class on the Rockford campus in August 2010. Linda Chang, PharmD, and Isaac Cha, PharmD, have joint faculty appointments with the College of Pharmacy and the College of Medicine at Rockford Department of Family and Community Medicine. Dr. Chang maintains a clinical practice at the University Family Health Center at Rockford where she sees patients and instructs family practice residents and pharmacy students during their ambulatory care rotations. She also provides a number of lectures and workshops in the PDAT series for the College of Pharmacy and the M2 pharmacology course for the College of Medicine. Dr. Chang is the course coordinator for the essentials of patient care course for second year medical students at the College of Medicine and lectures extensively in the course. Dr. Cha maintains a clinical practice at the University Primary Care Clinic at Mt. Morris where he sees patients and teaches both pharmacy and medical students during their clinical rotations. Dr. Cha also lectures in the PDAT series for the College of Pharmacy and is the course coordinator for the College of Medicine second year pharmacology course. He lectures extensively in the M2 pharmacology course and conducts many active learning workshops for the students. Jennifer George, PharmD, is a clinical assistant professor who is jointly funded by Crusader Clinic in Rockford where she maintains her clinical practice. Dr. George teaches pharmacy students during the ambulatory care rotations and has become more active in the College of Pharmacy with the expansion of the Rockford campus.

The development of the Rockford campus required additional pharmacy practice faculty members to help with both didactic and clinical teaching. In March 2010, Allison Schriever, PharmD, was hired as the director of experiential education for the Rockford campus. Dr. A. Schriever develops clinical sites for pharmacy student IPPE and APPE rotations. She has been

instrumental in the development and implementation of the Rural Pharmacy Education Program at the Rockford campus. Christopher Schriever, PharmD, joined the department in September 2010. Dr C. Schriever is jointly funded by Crusader Clinic. He is an integral part of the HIV patient management team and he serves on a number of critical infection control and quality assurance committees at Crusader Clinic. Dr C. Schriever is also a lecturer in the infectious disease portion of the College of Pharmacy PDAT series.

18

2010 In

Review

Research Activities Jim Fischer, Assistant Head for Research

The department continued to advance its research mission with several new initiatives during the last year. In November, the first Department Research Poster Forum was held with more than 20 individuals participating. The forum provided the opportunity for faculty to educate others in the department about their research activities, receive feedback from colleagues, and establish collaborations. A program of monthly research seminars organized around the topics of clinical pharmacology and individualized drug therapy also started in November. The seminar series was supplemented by a pharmacogenomics lecture series of invited external speakers from January through April. An important need identified in the department’s research strategic plan was the need to provide structured programs to enhance the research knowledge and skills of the faculty. The department, in conjunction with the Office of the Vice Chancellor for Research, is planning to offer a day-long program titled, Writing Winning Grants and Coping with Changes at NIH, to begin to address the identified concerns. Both the quality and size of the research program grew during the last year. The department added new tenure track faculty. A 1,500-square-foot expansion of laboratory space and much needed renovation of the current laboratories are planned. Information on publications as well as externally funded grants and contracts is listed in a separate section of this report.

19

2010 In

Review

Department Research Funding

Schizophrenia Pharmacogenetics: cognition and symptom response to antipsychotics Funding Source: National Institute of Mental Health Investigator: Jeffrey R. Bishop Time Period: April 2009–December 2013 Clinical and Computational Studies of Dopamine Function in First Episode Schizophrenia Funding Source: Ortho McNeil Janssen Scientific Affairs Investigator: Jeffrey R. Bishop Time Period: November 2008–June 2015 Affective Neuroscience of Pediatric Bipolar Disorder Funding Source: National Institute of Mental Health Investigator: Mani Pavuluri PMPR CO-Investigator: Jeffrey R. Bishop Time Period: January 2009–November 2013 Genetic and electrophysiology biomarkers for depression and anxiety: a multidisciplinary investigation Funding Source: University of Illinois Vice Chancellor for Research Investigator: Jeffrey R. Bishop Time Period: January 2010–December 2011

Risperidonepharmacogenetics: the role of the type-3 metabotropic glutamate receptor in cognition and negative symptom response Funding Source: NARSAD Investigator: Jeffrey R. Bishop Time Period: July 2008–June 2011 Functional and Clinical Significance of the CYP2C9 8 Allele Funding Source: American Heart Association Investigator: Larisa Cavallari PMPR Co-Investigators: Hyun-Young Jeong, Edith Nutescu, Nancy Shapiro Time Period: July 2010–June 2012 JBVAMC VA Contract Funding Source: Jesse Brown VA Investigator: Janet Engle Time Period: March 2009–June 2011 Virtual Eye (VE) and Virtual Scene (VS) Funding Source: Allergan, Inc. Investigator: Richard Fiscella Time Period: January 2009–January 2011 Medication Monitoring & Safety in Older Adults (MMSOA): A Community-Based Educational Outreach Program Funding Source: Age Options Investigator: Kristen Goliak PMPR Co-Investigators: Michael Koronkowski Time Period: October 2009–September 2010

Medication Monitoring & Safety in Older Adults (MMSOA): A Community-Based Educational Outreach Program Funding Source: Age Options Investigator: Kristen Goliak PMPR Co-Investigators: Michael Koronkowski Time Period: September 2010–October 2011 Regulation of genes involved in hepatic drug elimination by female hormones Funding Source: National Institute of Child Health and Human Development Investigator: Hyun-Young Jeong

PMPR Co-Investigator: James Fischer Time Period: July 2008–June 2010 Development of PLpro and 3CLpro Protease Inhibitors as Novel SARS Therapeutics Funding Source: National Institute of Allergy and Infectious Disease Investigator: Michael E. Johnson PMPR Co-Investigator: Hyun-Young Jeong Time Period: July 2010–July 2011

2010 In

Review

20

A Dietary-Based Xanthone for Prostate Cancer Chemoprevention Funding Source: National Cancer Institute Investigator: Jeremy Johnson Time Period: September 2009–August 2011 CONCERT-Clinical Effectiveness Research (CONCERT-CER) Funding Source: NHLBI, through University of Chicago Investigators: Todd Lee, A. Simon Pickard PMPR Co-Investigators: A. Simon Pickard, Glen Schumock Time Period: October 2009–September 2011

High Value Healthcare Through Better Information and Quality Improvement: Characterizing Episodes Funding Source: American Board of Medical Specialties Investigator: Todd Lee Time Period: January 2009–May 2010 Effect of Chronic Illness Complexity on Evidence-Based Depression Treatment Funding Source: Agency for Healthcare Research and Quality Principal Investigator: Neil Jordan, Northwestern University PMRP CO-Investigator: Todd Lee Time Period: September 2008–August 2010

Chemopreventive properties of Medicinal and Food plants of the Lumbee Tribe Funding Source: National Center for Complementary & Alternative Medicine Investigator: Tracie D. Locklear PMPR Co-Investigator: Gail Mahady Time Period: August 2008–July 2011 Medication Adherence Training Program for Pharmacists Funding Source: Medco Health Solutions, Inc. Investigator: Mary Moody PMPR Co-Investigator: Daniel Touchette Time Period: March 2009–June 2012 Update of DHS Drug Interaction System Funding Source: Illinois State Department of Human Services Investigator: Mary Moody Time Period: October 2009–June 2010 Update of DHS Interaction System Funding Source: Illinois State Department of Human Services Investigator: Mary Moody Time Period: July 2010–June 2011

Barriers to appropriate Anticoagulation With Warfarin to Orthopedic Surgery Funding Source: Ortho McNeil Janssen Scientific Affairs Investigator: Edith Nutescu PMPR Co-Investigators: Glen Schumock, Adriana Bautista Time Period: February 2009–July 2011 Evaluation of the ProTimeInRhythmMicrocoagulation System by Inexperienced Patients Self-Testers Funding Source: International Technidyne Corporation Investigator: Edith Nutescu PMPR Co-Investigator: Larisa Cavallari Time Period: July 2010–June 2011 AnticoaglationSelf Management in Underserved Minority Patients Funding Source: National Center for Research Resources PMPR CO-Investigator: Edith Nutescu Time Period: January 2010–January 2012

2010 In

Review

21

Takeda Pharmaceuticals International & UIC 2 year Fellowship in Health Economics and Outcomes Research Funding Source: Takeda Pharmaceuticals International Investigator: Simon Pickard PMPR Co-Investigators: Glen Schumock, Daniel Touchette Time Period: November 2010–November 2012 Takeda Pharmaceuticals Products Inc and UIC 2 year Fellowship in Health Economics and Outcomes Research Funding Source: Takeda Pharmaceuticals International Investigator: A. Simon Pickard PMPR Co-Investigators: Glen Schumock , Daniel Touchette Time Period: October 2009–October 2011 Robustness of medication exposure definitions related to patterns of medication use for comparativeness effectiveness in COPD Funding Source: Novartis Investigator: A. Simon Pickard PMRP Co-Investigator: Todd Lee Time Period: October 2009–November 2010 Novo Nordisk & University of Illinois at Chicago Fellowship in Health Economics and Outcomes Research Funding Source: Novo Nordisk Principal Investigator: A. Simon Pickard Time Period: July 2007–June 2010 Depression Care Facility-Level Variation for Persons with Multimorbidity Funding Source: Jesse Brown VA Principal Investigator: A. Simon Pickard PMRP CO-Investigators: A. Simon Picard, Todd Lee Time Period: October 2009–September 2010

Doripenem Disposition in Cerebrospinal Fluid in Subjects with External Ventriculostomy Funding Source: Ortho McNeil Janssen Scientific Affairs Investigator: Keith Rodvold PMPR Co-Investigator: Eljim Tesoro Time Period: December 2008–November 2011 Doripenem Intrapulmonary Pharmacokinetics in Healthy Adult Subjects Funding Source: Ortho McNeil Janssen Scientific Affairs Investigator: Keith Rodvold Time Period: December 2008–June 2011 DECIDE 2 – Administrative Support Funding Source: Agency for Healthcare Research & Quality Investigator: Glen Schumock PMPR Co-Investigators: A. Simon Pickard, Todd Lee Time Period: September 2010–September 2011 Medical Economics Center for Education and Research on Therapeutics (CERT): Validating Performance Measures for Patients Hospitalized with COPD Exacerbations and Using Social Network Analysis to Guide Quality Improvement Team Formation Funding Source: Agency for Healthcare Research and Quality Center Principal Investigator: David Meltzer, University of Chicago PMPR Co-Investigator: Glen Schumock Time Period: September 2007–August 2011 UC/UIC Comparative Effectiveness Research Institutional Career Development Award Funding Source: University of Chicago National Cancer Institute Investigator: David Meltzer, University of Chicago PMPR CO-Investigator: Glen Schumock Time Period: August 2010–August 2011

2010 In

Review

22

General DEcIDE Network Support: Methods and Dissemination Funding Source: Agency for Healthcare Research and Quality Investigator: Glen Schumock PMPR CO-Investigators: Todd Lee, A. Simon Pickard Time Period: September 2008–September 2010 Comparative Effectiveness of Breast Imaging Modalities: A natural experiment Funding Source: Agency for Healthcare Research and Quality Principal Investigator: Garth Rauscher, School of Public Health PMPR CO-Investigator: Glen Schumock Time Period: September 2010–August 2015 UIC Centers for Education and Research in Therapeutics (CERT): Design, Implementation and Dissemination of Medication Prescribing Guidelines in a National Consortium of Health Systems: Translation of Evidence into Practice Funding Source: Agency for Healthcare Research and Quality Center Principal Investigator: Bruce Lambert PMPR CO-Investigator: Glen Schumock Time Period: September 2007–August 2011 UIC Centers for Education and Research in Therapeutics (CERT): Pharmacoeconomics: Empowerment Tool for Formulary Process Funding Source: Agency for Healthcare Research and Quality Center Principal Investigator: Bruce Lambert PMRP CO-Investigators: Daniel Touchette Time Period: September 2007–August 2011 2010 Pharmacy Residency Stipend Support Program Funding Source: Amgen, Inc. Investigator: Eljim Tesoro Time Period: July 2010–June 2011

Assessment of a Telepharmacy Robotic Medication Dispending Unit in Military Warrior Transition Units Funding Source: InRange Systems Inc. Investigator: Daniel Touchette PMPR Co-Investigator: Vicki Groo Time Period: March 2009–December 2011 Assessment of Identification of Therapeutic Gaps and Community Pharmacist Intervention in State of Illinois Employees Funding Source: Medco Investigator: Daniel Touchette PMPR Co-Investigators: Jessica Tilton, JoAnn Stubbings, Mary Moody Time Period: January 2010–December 2011

2010 In

Review

23

Publications

Adeniyi BA, Lawal TO, Mahady GB, Franzblau S. In vitro susceptibility of mycobacterium tuberculosis h37rv to extracts of eucalyptus camaldulensisdehn. And eucalyptus torelliana f. Muell. Fitoterapia. 2010. Akkina S, Campara M, Anattiwong P, Oberholzer J, Benedetti E, Lau A, Tang I. Effectiveness of vitamin D repletion in the correction of persistent secondary hyperparathyroidism in kidney transplant recipients. Am J Transplant. 2010; 10(SupplS4): 518.

Alaraj A, Wallace A, Tesoro E, Ruland S, Amin-Hanjani S, Charbel FT, Aletich V. Heparin-induced thrombocytopenia: diagnosis and management – a review for the neurointerventional surgeon. J Neuro Intervention Surg. 2010; 2: 371-78. Anattiwong P, Campara M, Lau A, Walczak D, McClure E, Obeholzer J, Benedetti E, Akkina S, Tang I. Vitamin d status in new kidney transplant recipients in a multi-ethnic post-transplant clinic. Am J Transplant. 2010; 10(SupplS4): 519. Bartlett JD, Bennett E, Fiscella RG, Jaanus SD, Editorial

panel for ophthalmic drug facts. 20th ed. St. Louis:

Wolters Kluwer Health, Facts and Comparisons; 2010.

Beri R, Chunduri S, Sweiss K, Peace DJ, Mactal-Haaf C, Dobogai LC, Shord S, Quigley JG, Chen YH, Mahmud N, Rondelli D. Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen. Bone Marrow Transplant. 2010 Feb; 45(2): 249-53. Bickham P, Golembiewski J. Contrast media use in the operating room. J Perianesth Nurs. 2010; 25: 94-103. Bishop JR and Bishop DL. How to prevent serotonin syndrome from drug-drug interactions. Current Psychiatry. 2010.

Bishop JR and Bishop DL. Iloperidone for the treatment of schizophrenia. Drugs Today (Barc). 2010; 46)8: 567-79. Bishop JR and Chae S. Should you order genetic testing to identify poor metabolizers in patients taking antipsychotics. Current Psychiatry. 2010. Brennan NJ, Lee TA, Wilk AS, Lyttle CS, Weiss KB. Defining an episode of care for colonoscopy: work of the high value health care project characterizing episodes and costs of care. Gastrointest Endosc Clin N Am. 2010; 20: 735-50. Burton M, Munger M, Bednarczyk E, Davis L, Davis G, Elliot MB, Maurey J, Seaton T, Touchette D, Zimmer-Young J. Update: The clinical pharmacist as principal investigator. Pharmacotherapy. 2010; 30(12): 1314. Campara M, Tzvetanov IG, Oberholzer, J. Interleukin-2 receptor blockade with humanized monoclonal antibody for solid organ transplantation. Expert Opin Biol Ther. 2010; 10(6): 959-69. Cavallari LH, Groo VL, Viana MAG, Dai Y, Patel SR, Stamos TD. Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure. Pharmacotherapy. 2010; 30: 1-9. Cavallari LH, Langaee TY, Momary KM, Shapiro NL, Nutescu EA, Coty WA, Viana MAG, Patel SR, Johnson JA. Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans. Clin Pharmacol Ther. 2010; 87(4): 459-64. Cavallari LH, Overholser BR, Anderson D, Boyce E, Buie L, Formea CM, Gallagher JC, Hayney MS, Oestreich J. Recommended basic science foundation necessary to prepare pharmacists to manage personalized pharmacotherapy. Pharmacotherapy. 2010; 30: 228e-35e.

2010 In

Review

24

Cavallari LH, Patel SR, Blekhman Y, Groo VL, Stamos TD. NPPA genotype is associated with aldosterone breakthrough in heart failure. J Cardiac Fail. 2010; 16 (8): S38. Cavallari L, DiDomenico R, Peksa G. Coronary Artery Disease. In: Katz MD, Matthias KR, Chisholm-Burns MA (eds). Pharmacotherapy principles & practice study guide: a case based care plan approach. 1st ed. New York: McGraw-Hill Companies; 2010. Chan J. Handbook of clinical drug data. 11th ed. Stamford: Appleton & Lange; c2010. Hepatitis Antiviral Drugs, p. 255-70. Chan J. Handbook of clinical drug data. 11th ed. Stamford: Appleton & Lange; c2010. Inflammatory bowel disease; p. 717-28. Chan J. Pharmacotherapy principles & practice. 2nd ed. New York: McGraw-Hill; c2010. Chapter 24,Viral hepatitis; p. 413-429. Colvard M, Naiman, M, Danziger L, Hanley L. Handheld directed energy sensor for environmental monitoring and clinician safety. Aviat Space Environ Med. 2010; 81: 602-04. Culos K, Cannon J, Grim SA. Alternative agents to vancomycin for the treatment of methicillin-resistant staphylococcus aureus (MRSA) infections. Am J Ther. 2010; E-publication. Davis LT, Kumar N, Nijm LM, Ulanski LJ, Tu EY, Fiscella R, Peterson R, Glickman RD. An adaptable HPLC method for the analysis of frequently used antibiotics in ocular samples. J Chrom B. 2010: 878; 2421-26. Delle Torre M, Hibbard JU, Jeong H, Fischer JH. Betamethasone in pregnancy: influence of maternal body weight and multiple gestation on pharmacokinetics. Am J ObstetGynecol. 2010; 203: 254 e1-12.

DePue RJ, Stubbings JA and Baker DB. Medicare part D policy update and implications for 2010. Am J Manag Care. 2010; 16(5): e117-20. DiDomenico RJ, Kondos GT, Dickens C. Trends in heart failure readmissions, risk-stratification, and nonadherence. Circ Heart Fail. 2010; 3: e13. DiDomenico RJ. Handbook of Clinical Drug Data. 11th ed. Chicago: McGraw-Hill; c2010. Chapter 35, Cardiovascular drugs: inotropic drugs; p. 494-516. DiDomenico R. Handbook of Clinical Drug Data, 11th ed. Chicago: McGraw-Hill; c2010. Cardiovascular drugs: nitrates. DiDomenico R. Pharmacotherapy principles & practice study guide: a case based care plan approach. Chicago: McGraw-Hill; c2010. Chapter 4, Ischemic Heart Disease. DiDomenico R, Cavallari L. Cardiovascular pharmacotherapy: a point of care guide. 1st ed. Bethesda: American Society of Health-System Pharmacists; c2010. Chapter 6, Chronic Stable Angina; p. 121-42. Djuric Kachlic M. Non-Prescription Self-Treatment of GERD. America’s Pharmacist. 2010 May; 37-50. Ellinger L, Ipema H, Stachnik J. Efficacy of metformin and topiramate in prevention and treatment of antipsychotic-induced weight gain. Ann Pharmacother. 2010; 44: 668-79. Evans CT, Li K, Burns SP, Smith B, Lee TA, Weaver FM. Antibiotic prescribing for acute respiratory infection and subsequent outpatient and hospital utilization in veterans with spinal cord injury and disorder. PM R. 2010; 2: 101-09. Fiscella R, Lesar T, Edward D. Pharmacotherapy: A Pathophysiologic Approach. 8th ed. McGraw Hill; c2010. Chapter 103, Glaucoma.

2010 In

Review

25

Fiscella R. Weighing the choice between generic and branded drugs. J Cat Refract Surg Today. 2010 June. CE. Gabay M. Academic detailing and the IDEA act. Hospital Pharmacy. 2010; 45: 839-40. Galanter WL, Thambi M, Rosencranz H, Shah B, Falck S, Lin FJ, Nutescu E, Lambert B. Effects of clinical decision support on venous thromboembolism risk assessment, prophylaxis, and prevention at a university teaching hospital. Am J Health Syst Pharm. 2010. 67: 1265-73. Galanter W L, Liu X, Lambert B. An analysis of computer alerts suggesting oral medication use during computerized order entry of intravenous medications. Am J Health Syst Pharm. 2010; 67: 1101-05. Galanter WL, Moja J, & Lambert B. L. Using computerized provider order entry and clinical decision support to improve prescribing in patients with decreased GFR. Am J Kidney Dis. 2010; 56(5): 809-12. Galanter WL, Thambi M,Rosencranz H, Shah B, Falck S, Lin F, Nutescu E, Lambert B. Clinical decision support to improve venous thromboembolism risk assessment, prophylaxis, and prevention at a university teaching hospital. Am J Health Syst Pharm. 2010; 67: 1265-73. George JM, Fiscella R, Blair M, Rodvold K, Ulanski L, Stokes J, Blair N, Pontiggia L. Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration. J Ocul Pharmacol Ther. 2010; 26: 579-56. Gerber BS, Cano AI, Caceres M, Smith DE, Wilken LA, Michaud JB, Ruggiero LA, Sharp LK. A pharmacists and health promoter team to improve medication adherence among Latinos with diabetes. Ann Pharmacother. 2010; 44: 70-9.

Golembiewski J, Rakic AM. Opioids. J Perianesth Nurs. 2010; 25: 258-260. Golembiewski J, Rakic AM. Sublingual buprenorphine. J Perianesth Nurs. 2010; 25: 413-15. Greenhalgh E, DiDomenico RJ. Predictors of diuretic resistance in patients with acute decompensated heart failure. Am J Cardiol. 2010. Grim SA, Pereira E, Guzman G, Clark NM. CMV PCR as a diagnostic tool for CMV gastrointestinal disease after solid organ transplantation. Transplantation. 2010; 90: 799-01. Habibi M. Movement Disorders. Oxford: Elsevier Limited; c2010. Acetycholine: p. 58-59. Habibi M. Movement Disorders. Oxford: Elsevier Limited; c2010. Dopamine Receptors. Habibi M. Movement Disorders. Oxford: Elsevier Limited; c2010. Primidone and Movement disorders. Hensley E, Briars L. Closer look at autism and the measles-mumps-rubella vaccine. J Am Pharm Assoc. 2010; 50: 48-53. Hill SK, Bishop JR, Palumbo D, Sweeney JA. Effect of second-generation antipsychotics on cognition: current issues and future challenges. Expert Rev Neurother. 2010; 10: 43-57. Hoffman JM, Doloresco F, Vermeulen LC, Shah ND, Matusiak L, Hunkler RJ, Schumock GT. Projecting future drug expenditures – 2010. Am J Health Syst Pharm. 2010; 67(11): 919-28. Hong I, Gabay M, Lodolce A. Safety concerns involving transdermal patches and magnetic resonance imaging. Hosp Pharm. 2010;45(10): 771-78. Hong I, Stachnik J. Unlabeled uses of factor VIIa (recombinant) in pediatric patients. Am J Health-Syst Pharm. 2010; 67: 1901-19.

2010 In

Review

26

Hong IS, Bishop JR. Anticholinergic use in children and adolescents taking antipsychotics. Ann Pharmacother. 2010; 44(7-8): 1171-80. Houston J, Dharia S, Bishop JR, Ellingrod VL, Fijal B, Jacobsen JG, Hoffman VP. Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women. Psychiatry Res. 2010; 187(1-2): 74-79. How P, Mason D, Arruda J, Lau A. Efficacy of chewed vs. crushed lanthanum on phosphorus binding in healthy volunteers. Clinical Nephrology. 2010; 73: 370-73. How PP, Anattiwong P, Arruda J, Lau A. Phosphate binding efficacy of chewed vs. crushed lanthanum carbonate in hemodialysis patients. Hemodial Int. 2010; E-publication. Hynes D, Tarlov E, Durazo-Arvizu R, Perrin R, Zhang Q, Weichle T, Ferriera M, Lee TA, Benson A, Bhoopalam N, Bennett C. Surgery and adjuvant chemotherapy use among veterans with colon cancer: insights from a California study. J Clin Oncol. 2010; 28: 2571-76. Hyunh D, Benavides S, Morgan J, Briars L. Approach to a pediatric prescription in a community pharmacy. The Journal of Pediatric Pharmacology and Therapeutics. 2010. Jagasia MH, Savani BN, Neff A, Dixon S, Chen H, Pickard AS. Outcome, toxicity profile and cost analysis of autologous stem cell mobilization. Bone Marrow Transplant. 2010; 1. Jeong H. Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes. Expert Opin Drug Metab Toxicol. 2010; 6: 689.

Johnson JJ, Syed D, Rasmussen J, Adhami V, Siddiqui I, Kohl A,Mukhtar H. alpha-mangostin, a xanthone from mangosteen fruit, inhibits CDK4 leading to G1 cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis. 2010. Johnson JJ,Nihal M, Siddiqui I, Scarlett C, Bailey H, Mukhtar H, Ahmad N. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res. 2010; E-publication. Johnson JJ, Syed DS, Suh Y, Heren CR, Saleem M, Siddiqui IA, MukhtarH. Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpenecarnosol: implications for chemoprevention. Cancer Prev Res. 2010; 3: 1112-23. Johnson JJ. Carnosol: a promising anti-cancer agent. Cancer Letters. 2010; 305: 1-7. Joo MJ, Au DH, Fitzgibbon ML, Lee TA. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Respir Med. 2010; 104: 246-52. Joseph J, Fiscella R, Blair M, et al. Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration. J Ocular Pharm Ther. 2010; 26: 579-86. Kiser KL, Badowski ME. Risk factors for venous thromboembolism in patients with human immunodeficiency virus infection. Pharmacotherapy. 2010; 30: 1292-1302. Kraus D. Antibiotic and Chemotherapy: Anti-Infective Agents and Their Use in Therapy. 9th ed. New York: Elsevier; c2010. Drug Interactions Involving Anti-Infective Agents. Lau DT, Berman R, Halpern L, Pickard AS, Schrauf R, Witt W. Exploring factors that influence informal caregiving in medication management for home hospice patients. J Palliat Med. 2010; 13(9): 1085-90.

2010 In

Review

27

Lawal TO, Soni KK, Adeniyi BA, Mahady GB. Antihelicobacter activities of natural compounds. Molecules (Switzerland). 2010. Lee TA, Chang CL, Stephenson JJ, Sajjan SG, Maiese EM, Everett S, Allen-Ramey F. Impact of asthma controller medications on medical and economic research utilization in adult asthma patients .Curr Med Res Opin. 2010; 26: 2851-60. Li ZH, Alex D, Siu SO, Chu IK, Renn J, Winkler C, Lou S, Tsui SK, Zhao HY, Yan WR, Mahady GB, Li GH, Kwan YW, Wang YT, Lee SM. Combined in vivo imaging and omics approaches reveal metabolism of icaritin and its glycosides in zebrafish larvae. Mol Biosyst. 2010; E-publication. Limdi NA, Limdi MA, Cavallari L, Anderson AM, Crowley MR, Baird MF, Allon MD, Beasley TM. Warfarin dosing in patients with impaired kidney function. Am J Kidney Dis. 2010; 56(5): 823-31. Limdi NA, Wadelius M, Cavallari L, Eriksson N, Crawford DC, Lee MT, Chen CH, Motsinger-Reif A, Sagreiya H, Liu N, Wu AH, Gage BF, Jorgensen A, Pirmohamed M, Shin JG, Suarez-Kurtz G, Kimmel SE, Johnson JA, Klein TE, Wagner MJ. Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood. 2010; 115: 3827-34. Lin HW, Pickard AS, Mahady GB, Karabatsos G, Crawford SY, Popovich NG. An instrument to evaluate pharmacists' patient counseling on herbal and dietary supplements. Am J Pharm Educ. 2010; 74(10): 192. Lindley KJ, Limdi N, Cavallari LH, Perera M, Lenzini P, Johnson J, Wu A, Ridker PM, Patel S, King C, Shah S, Eby CS, Beasley TM, Gage BF. Warfarin dosing in patients with the CYP2C9*5 variant. Circulation. 2010: A16860.

Locklear TD, Huang Y, Frasor J, Doyle BJ, Perez A, Gomez-Laurito J, Mahady GB. Estrogenic and progestagenic effects of extracts of JusticiapectoralisJacq an herbal medicine from Costa Rica used for the treatment of menopause and PMS. Maturitas 2010; 66: 315-22. Low Dog T, Barrett ML, Mahady GB, Chavez ML, Gardiner P, Ko R, Marles RJ, Pellicore LS, Giancaspro G, Sarma D. Assessing the safety of herbal supplements for women’s health: An International Perspective. Maturitis 2010; 66: 355-52. Mahady G, Low Dog T, Sarma ND, Giancaspro GI, Griffiths J. The causal relationship between the use of black cohosh-containing products and hepatotoxicity. Menopause. 2010; 17: 1088-98. Mahady GB, Low Dog T, Sarma D. Suspected black cohosh hepatoxicity-causality assessment versus safety signal. Maturitas. 2010; 66. Mahady G. Bioactive Natural Products. Amsterdam: Elsevier Science Publishers; c2010. Antihelicobacter activities of natural compounds. Mahady, G. Annals of traditional Chinese medicine. Vol. 4, Health Aging. Hong Kong: World Scientific; c2010. Chapter 4, Botanicals for Aging; p. 54-92. Mahady G.Encyclopedia of dietary supplements. 2nd ed. New York: Informa Healthcare; c2010. Chapter 18, Cascara Sagrada. Mahady G. Studies in Natural Products 2. Amsterdam: Elsevier Science; c2010. Natural Products as Antibacterial Agents. Mahady G. Encyclopedia of Dietary Supplements. 2nd ed. New York: Marcel Dekker; c2010. Chapter 19, Vitexagnuscastus.

2010 In

Review

28

Mancuso CE, Gabay MP, Steinke LM, VanOsdol SJ. Peramivir: An intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza. Ann Pharmacother. 2010; 44(7-8): 1240-49. Marles R, Gardiner P, Sarma DN, Low Dog T, Barrett ML, Chavez ML, Ko R, Mahady GB, MarlesRJ, Pellicore LS, Giancaspro G. United States pharmacopoeia safety evaluation of spirulina. Crit Rev Food Sci Nutr. 2010; 51(7): 593-604. Martin MT, Kuchta AM, Nutescu EA. A clinician’s guide to perioperative bridging for patients on oral anticoagulation. J Pharm Pract. 2010; 23: 303-12. Martin MT, Shah BH. In: Domina FJ, ed. 5-Minute Clinical Consult. Philadelphia: Lippincott Williams & Wilkins; c2010. Angioedema. Meltzer D, Chung J, Khalili P, Marlow E, Arora V, Schumock G, Burt R. Exploring the use of social network methods in designing healthcare quality improvement teams. Soc Sci Med. 2010; 71: 1119-30. Michaud J. 5-minute clinical consult. Philidelphia: Lippincott Williams & Wilkins; c2010. Onychomycosis. Michel JL, Chen Y, Zhan H, Huang Y, Krunic A, Orjala J, Veliz M, Soejarto DD, Caceres A, Perez A, Mahady G. Estrogenic and serotonergic butenolides from the leaves of Piper hispidumSwingle (Piperaceae). Journal of Ethnopharmacology. 2010; 129: 220-26. Momary K, Cavallari LH. Clopidogrel and proton pump inhibitors: between a rock and a hard place. Pharmacotherapy. 2010; 30: 762-5. Nimmagadda S, Sweiss K, Mahmud N, Park Y, Rondelli D. Plerixafor given before the third leukapheresis to rescue an unsuccessful stem cell mobilization with CY and G-CSF. Bone Marrow Transplant. 2010 Jun; 45(6): 1121-2.

Nutescu EA, Tiryaki F, Lambert B, Schumock G. Compliance of US hospitals with national guidelines and performance measures for anticoagulant therapy in venous thrombosis prevention and management. Pathophysiol Haemost Thromb. 2010; 37(suppl 1): A26-OC564. Nutescu E. Anticoagulation management services: entering a new era. Pharmacotherapy . 2010; 30(4): 327-9. Nutescu E. Pharmacotherapy Principles and Practice. 2nd ed. New York: McGraw-Hill; c2010. Chapter 10, Venous Thromboembolism; p. 185-214. Ogale SS, Lee TA, Au DH, Boudreau DM, Sullivan SD. Cardiovascular events associated with ipratropium bromide in COPD. Chest. 2010; 137: 13-19. Oliveros M, Pham JT, John E, Resheidat A, Bhat R. The Use of Bumetanide in Oliguric Acute Renal Failure in Preterm Infants. Pediatr Crit Care Med. 2010. Osis L, Bishop JR. Pharmacogenetics of SSRIs and sexual dysfunction. Pharmaceuticals. 2010 Panos N, Tesoro E, Kim K, Mucksavage J. Outcomes associated with the use of transdermal nicotine replacement therapy in a neurosurgery intensive care unit. Am J Health Syst Pharm. 2010; 67: 1357-61. Patel P, Sweiss K, Nimmagadda S, Gao W, Rondelli D. Comorbidity index does not predict outcome in allogeneic myeloablative transplants conditioned with fludarabine/i.v. busulfan (FluBu4). Bone Marrow Transplant. 2010; E-publication. Patel P, Sweiss K, Shatavi S, Peace D, Clark N, Rondelli D. The impact of novel influenza A (H1N1) after hematopoietic SCT. Bone Marrow Transplant. 2010 Dec; 45(12): 1756-7.

2010 In

Review

29

Perez K, Givone DM, Toth J. Heart failure exacerbation caused by serotonin-norepinephrine reuptake inhibitors in a veteran population. J Pharm Pract. 2010; 23: 153-187. Rodvold KA, Kraus DM. Antibiotic and Chemotherapy: Anti-Infective Agents and Their Use in Therapy. New York: Elsevier; c2010. Drug interactions involving anti-infective agents. Schumann H. Clinical Drug Data. 11th ed. New York: McGraw-Hill; c2010. Chapter 76, Cardiac Arrest; p. 1193-1202. Shapiro NL, Bursua A. Pharmacotherapy Self-Assessment Program. 7th ed. Cardiology. Lenexa, KS: American College of Clinical Pharmacy, c2010. Venous Thromboembolism Prevention and Treatment: Evidence Based Updates, p.65-90. Shaw JW, Pickard AS, Yager RR. Application of directional statistics to health state valuation: a commentary on craig and oppe. Soc Sci Med. 2010; 71(3): 429-30. Shaw JW, Pickard AS, Yu S, Chen S, Iannacchione VG, Johnson JA, Coons SJ. A median model for predicting United States population-based EQ-5D health state preferences. Value Health. 2010; 13(2): 278-88. Shord S, Chan L, Camp JR, Vasquez EM, Jeong H, Molokie RE, Baum CL, Xie H. Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam. Br J Clin Pharmacol. 2010; 69: 160. Smith KM, Sorenson T, Connor KA, Dobesh PP, Hoehns JD, Marcus KB, Pass S, Seybert AL, Shapiro NL. Value of Conducting Pharmacy Residency Training – The Organizational Perspective. Pharmacotherapy. 2010: 30(12); 1313-1313. Smyythe MA, Nutescu EA, Wittkowsky AK. Changes in the USP heparin monograph and implications for clinicians. Pharmacotherapy. 2010; 30(5): 428-31.

Snedecor SJ, Botteman MF, Schaefer K, Sarocco P, Barry N, Pickard AS. Economic outcomes of eszopiclone treatment in insomnia and comorbid major depressive disorder. J Ment Health Policy Econ. 2010; 13(1): 27-35. Sohn MW, Budiman-Mak E, Stuck RM, Siddiqui F, Lee TA. Diagnostic accuracy of existing methods for identifying diabetic foot ulcers from inpatient and outpatient datasets. J Foot Ankle Res. 2010; 3: 27. Sohn MW†, Stuck RM, Pinzur M, Lee TA, Budiman-Mak E. Lower extremity amputation risk following Charcot arthropathy and diabetic foot ulcer. Diab Care. 2010; 33: 98-100. Solomkin JS, Mazuski JE, Bradley J, Rodvold KA, Goldstein EJC, Baron EJ, O'Neill P, Chow A, Dellinger EP, Escachacmpati S, Gorbach S, Hilfiker M, May A, Nathens AB, Sawyer RG, Bartlett J. Diagnosis and managements of complicated intra-abdominal infections in adults and children: guidelines by the surgical infection society and the infectious diseases society of america. Clin Infect Dis. 2010; 50: 133-64. Solomkin JS, Mazuski JE, Bradley J, Rodvold KA, Goldstein EJC, Baron EJ, O'Neill P, Chow A, Dellinger EP, Escachacmpati S, Gorbach S, Hilfiker M, May A, Nathens AB, Sawyer RG, Bartlett J. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt). 2010; 11: 79-109. Soni KK, Lawal TO, Locklear TD, Mahady GB. Black cohosh: review of the clinical data and future perspectives. Drug Inf J. 2010; 45: 37-44. Stachnik J. Treatment of hemophilia. Formulary. 2010; 44: 668-79.

2010 In

Review

30

Stachnik J, Gabay M. Emerging role of aripiprazole for the treatment of irritability associated with autistic disorder in children and adolescents. J Adolesc Health. 2010; 1: 105-14. Stein BD, Bautista A, Charbeneau JT, Schumock GT, Lee TA, Lauderdale DS, Krishnan JA. Validity of ICD-9 code algorithms for identifying patients hospitalized for acute exacerbation of COPD. Am J Respir Crit Care Med. 2010; 181: A5350. Stein BD, Charbeneau JT, Lee TA, Schumock GT, Lindenauer PK, Bautista A, Naureckas ET, Krishnan JA. Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters. COPD. 2010; 7: 164-71. Stubbings JA, Joshi RA and Hoffman JM. Risk Evaluation Mitigation Strategies (REMS) – challenges and opportunities for health-system pharmacists. Am J Health Syst Pharm. 2010; 67: 1547-54. Stubbings JA, Kliethermes MA. Essentials of pharmacy management, leadership, marketing, and finance. Sadbury, MA: Jones and Bartlett ; c2010. Chapter 11, Justifying and planning patient care services; p. 217-35. Sundermann E, Maki PM, Bishop JR. A Review of Estrogen Receptor-á Gene (ESR1) Polymorphisms, Mood, and Cognition. Menopause. 2010; 17(4): 874-86. Syed DN, Afaq F, Maddodi N, Johnson JJ, Sarafaz S, Ahmad A, Setaluri V, Mukhtar H. Inhibition of human melanoma cell growth by dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels. J Invest Dermatol. 2010; 131(6): 1291-99. Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 17th Edition. Hudson, OH: Lexi-Comp Inc; c2010.

Tang I, Akkina S, Campara M, Anattiwong P, Oberholzer J, Benedetti E, Lau A. Vitamin D status of long-term kidney transplant recipients in a multi-ethnic post-transplant clinic. Am J Transplant. 2010; 10(SupplS4): 519. Tesoro EP, Brophy GM. Pharmacological management of seizures and status epilepticus in critically ill patients. J Pharm Pract. 2010; 23: 441-54. Tesoro E. Pharmacotherapy Principles and Practice. 2nd ed. New York: McGraw-Hill; c2010. Chapter 31, Status Epilepticus; p. 541-552. Thomas KLH, Ellingrod VL, Bishop JR, Keiser MJ. A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach. Psychopharmacol Bull. 2010; 41(1): 85-98. Touchette DR. Improving adherence in the community and clinic pharmacy settings: an emerging opportunity. Pharmacotherapy. 2010; 30: 425-27. Vaysman Markel A, Nutescu E. Factor Xa inhibitor for the prevention of deep vein thrombosis and venous thromboembolism. Curr Opin Investig Drugs. 2010; 11(3): 333-39. Vaysman Markel A, Schumacher C. The reform of the ambulatory care pharmacist. Keep Posted. 2010; 36(9): 14-15 Vaysman Markel A, Tilton J. Providing medication therapy management (MTM) in an outpatient clinic setting. KeePosted 2010; 36(8): 18-19. Vaysman Markel A. Protective Role of Vitamin D on Cardiovascular System. US Pharmacist 2010; 35(2): HS28-HS32. Voora D, Koboldt DC, King CR, Lenzini PA, Eby C, Porche-Sorbet R, Deych E, Crankshaw M, Milligan PE, McLeod HL, Patel SR, Cavallari LH, Ridker, PM, Grice

2010 In

Review

31

GR, Miller RD, Gage BF. A polymorphism in the VKORC1-regulator calumenin predicts higher warfarin dosesrequirements in African Americans. Clin Pharmacol Ther. 2010; 87: 445-51. Walton SM, Schumock GT, Alexander GC, Stafford RS. Importance of distinguishing supported and unsupported off-label drug use. Arch Intern Med. 2010; 170(7): 657-58. Walton SM, Schumock GT, McLain DA. Cost analysis of flavocoxid compared to naproxen for management of mild to moderate OA. Curr Med Res Opin. 2010; 26(9): 2253-61. West-Thielke P, Thielke J, Joseph J, Emmanuel N, Cheatem D, Oberholzer J, Benedetti E, Kaplan B. Oral loading of mycophenolic acid as enter-coated mycophenolic sodium (EC-MPS) in African American kidney transplant patients. Clin Transpl. 2010. Wilke CT, Pickard AS, Walton SM, Moock J, Kohlman T, Lee TA. Statistical implications of utility weighted and equally weighted HRQL measures: an empirical study. Health Econ. 2010; 19: 101-10. Wittkowsky AK, Spinler SA, Dager W, Gulseth MP, Nutescu EA. Dosing guidelines, not protocols, for managing warfarin therapy. Am J Health Syst Pharm. 2010; 67(18): 554-6. Wright S, Kurpius M, Ng J, Givone DM. An evaluation of the effectiveness and safety of varenicline in a veteran population. J Pharm Pract. 2010; 23: 153-87. Xamplas RC, Itokazu GS,Glowacki RC, Grasso AE, Caquelin C, Schwartz DN. Implementation of an extended-infusion piperacillin-tazobactam program at an urban teaching hospital. Am J Health Syst Pharm. 2010; 67: 622-8. Yang K, Koh KH, Jeong H. Induction of CYP2B6 and CYP3A4 by 1-Aminobenzotriazole (ABT) in human hepatocytes. Drug Metabolism Letter. 2010; 4: 129.

Yang Y, McBride MV, Rodvold KA, Tverdek F, Trese AM, Hennenfent J, Schiff G, Lambert BL, Schumock GT. Hospital policies and practices on prevention and treatment of infections caused by methicillin-resistant Staphylococcus aureus. Am J Health Syst Pharm. 2010; 67: 1017-24 Yu JM, Shord SS, Cuellar S. Transfusions increase with nationally driven reimbursement changes of eryrthropoiesis stimulating agents for chemotherapy induced anemia. J Oncol Pharm Pract. 2010; E-publication. Yue Huang E, Kennelly B, Nuntanakorn P, Shord S, Mahady G. Fukinolic acid derivatives and triterpenes from black cohosh extracts inhibit CYP 450 isozymes but are not cytotoxic to HepG2 cells in vitro. Current Drug Safety. 2010; 5: 118-24. Zarowitz BJ, Tangalos E, Lefkovitz A, Bussey H, Deitelzweig S, Nutescu EA, O’Shea T, Resnick B, Wheeler A. Thrombotic risk and immobility in residents of long term care facilities. J Am Med Dir Assoc. 2010; 11(3): 211-21.